Cargando…
Impact factor and citation metrics in phase III cancer trials
Purpose: Journal impact factor (IF) is often used to measure research quality and importance. We assessed trial factors associated with the publication of cancer trials in journals with higher IF and publications receiving higher citations. Materials and Methods: Cancer-specific phase III RCTs were...
Autores principales: | Abi Jaoude, Joseph, Kouzy, Ramez, Rooney, Michael, Thompson, Petria, Patel, Roshal, Turner, Maddie C., Ghabach, Marc, Fuller, C. David, Minsky, Bruce D., Taniguchi, Cullen M., Ludmir, Ethan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416560/ https://www.ncbi.nlm.nih.gov/pubmed/34504650 http://dx.doi.org/10.18632/oncotarget.28044 |
Ejemplares similares
-
Food and Drug Administration approvals in phase 3 Cancer clinical trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021) -
Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020) -
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Applying to Radiation Oncology Amid a Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020)